Suppr超能文献

随着时间的推移,估计肾小球滤过率的变化与全因死亡率的风险。

Change in the estimated glomerular filtration rate over time and risk of all-cause mortality.

机构信息

Department of Medicine, University of Calgary, Calgary, Alberta, Canada.

出版信息

Kidney Int. 2013 Apr;83(4):684-91. doi: 10.1038/ki.2012.443. Epub 2013 Jan 23.

Abstract

Using a community-based cohort we studied the association between changes in the estimated glomerular filtration rate (eGFR) over time and the risk of all-cause mortality. We identified 529,312 adults who had at least three outpatient eGFR measurements over a 4-year period from a provincial laboratory repository in Alberta, Canada. Two indices of change in eGFR were evaluated: the absolute annual rate of change (in ml/min per 1.73 m(2) per year) and the annual percentage change (percent/year). The adjusted mortality risk associated with each category of change in eGFR was assessed, using stable eGFR (no change) as the reference. Over a median follow-up of 2.5 years there were 32,372 deaths. Compared to the reference participants, those with the greatest absolute annual decline less than or equal to 5 ml/min per 1.73 m(2) per year had significantly increased mortality (hazard ratio of 1.52) adjusted for covariates and kidney function at baseline (last eGFR measurement). Participants with the greatest increase in eGFR of 5 ml/min per 1.73 m(2) per year or more also had significantly increased mortality (adjusted hazard ratio of 2.20). A similar pattern was found when change in eGFR was quantified as an annual percentage change. Thus, both declining and increasing eGFR were independently associated with mortality and underscore the importance of identifying change in eGFR over time to improve mortality risk prediction.

摘要

利用一个基于社区的队列,我们研究了肾小球滤过率(eGFR)随时间变化与全因死亡率风险之间的关系。我们从加拿大阿尔伯塔省的一个省级实验室数据库中确定了 529,312 名至少有三次门诊 eGFR 测量值的成年人,随访时间为 4 年。评估了 eGFR 变化的两个指标:绝对年度变化率(每年每 1.73m2 毫升/分钟)和年度百分比变化(%/年)。使用稳定的 eGFR(无变化)作为参考,评估了每个 eGFR 变化类别与调整后的死亡率风险之间的关系。在中位数为 2.5 年的随访期间,有 32,372 人死亡。与参考参与者相比,那些绝对年度下降值小于或等于 5 毫升/分钟/1.73m2/年的患者,调整了协变量和基线时的肾功能(最后一次 eGFR 测量值)后,死亡率显著增加(危险比为 1.52)。那些 eGFR 增加值最大的患者,即每年增加 5 毫升/分钟/1.73m2 或更多的患者,死亡率也显著增加(调整后的危险比为 2.20)。当 eGFR 的变化以年度百分比变化来量化时,也发现了类似的模式。因此,eGFR 的下降和上升都与死亡率独立相关,这强调了识别 eGFR 随时间变化以改善死亡率风险预测的重要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验